Article Details

Roche's Actemra adds another failure to spotty COVID-19 results—this time with Gilead's remdesivir

Retrieved on: 2021-03-11 15:22:30

Tags for this article:

Click the tags to see associated articles and topics

Roche's Actemra adds another failure to spotty COVID-19 results—this time with Gilead's remdesivir. View article details on hiswai:

Excerpt

As one of the earliest drugs proposed to treat COVID-19, Roche's arthritis therapy Actemra has already amassed a large pool of data for that use—but ...

Article found on: www.fiercepharma.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo